THE WHAT? THG has reported interim outcomes for the primary half of 2025, with income development returning within the second quarter and momentum anticipated to proceed into the second half of the 12 months.
THE DETAILS Group income for the six months to 30 June stood at £783.4m, a 2.6 % decline year-on-year at fixed forex, whereas adjusted EBITDA dropped to £24m from £37.1m within the prior 12 months. Gross margin fell to 41.1 %, in comparison with 42.6 % in H1 2024, largely impacted by file whey costs in Vitamin.
THG Magnificence posted revenues of £479.9m, down 5.9 % on a relentless forex foundation, attributed to portfolio rationalisation and market withdrawals in Europe and Asia. Nevertheless, administration pointed to latest model launches, together with Gucci Magnificence, and rising buyer loyalty at LookFantastic as drivers for a return to development from Q3.
THG Vitamin, led by Myprotein, grew revenues 3.1 % to £303.6m, with momentum accelerating in Q2. Myprotein expanded its US retail presence by way of Walmart listings and is concentrating on gross sales of 45 million models through offline and licensing channels this 12 months. The division additionally introduced upcoming partnerships in food-to-go and confectionery.
Strategic adjustments in 2024, the demerger of THG Ingenuity, and the £103m disposal of Claremont Elements are contributing to what administration described as an “accelerated path” towards a internet money place. For H2, THG forecasts income development of 1–3 % in Magnificence and 10–12 % in Vitamin.
THE WHY? The outcomes spotlight stabilisation after a 12 months of restructuring, with Magnificence positioned for renewed development and Vitamin persevering with to learn from world model enlargement and offline retail penetration.
Supply: Retail Gazette
